Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Krystal Biotech, Inc. (KRYS) had Pre-Tax Income of $51.13M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$107.11M |
|
$51.40M |
|
$6.59M |
|
$100.51M |
|
$62.67M |
|
$44.44M |
|
$6.70M |
|
|
Pre-Tax Income |
$51.13M |
$51.13M |
|
$51.40M |
|
$51.40M |
|
$51.40M |
|
$51.40M |
|
$44.44M |
|
$46.20M |
|
28.94M |
|
29.95M |
|
$1.77 |
|
$1.69 |
|
| Balance Sheet Financials | |
$1.02B |
|
$150.78M |
|
$309.19M |
|
$1.33B |
|
$102.94M |
|
-- |
|
$11.29M |
|
$114.23M |
|
$1.22B |
|
$1.22B |
|
$1.22B |
|
29.19M |
|
| Cash Flow Statement Financials | |
$200.87M |
|
$-58.42M |
|
$8.71M |
|
$344.87M |
|
$496.30M |
|
$151.44M |
|
$54.51M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.95 |
|
-- |
|
-- |
|
-- |
|
-- |
|
93.84% |
|
41.49% |
|
41.49% |
|
-- |
|
47.74% |
|
47.99% |
|
$189.35M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.16 |
|
0.84 |
|
107.07 |
|
4.21% |
|
4.21% |
|
3.85% |
|
4.21% |
|
$41.78 |
|
$6.32 |
|
$6.71 |
|